Clinical Trial: International Takotsubo Registry (InterTAK Registry)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: International Multicenter Registry on Takotsubo Cardiomyopathy

Brief Summary:

This is a multicenter, multinational, prospective and retrospective, observational study of patients with Takotsubo cardiomyopathy (TTC).

Data on natural profile (demographical characteristics, clinical phenotype, laboratory values, electrocardiography parameters, echocardiography parameters, coronary angiography parameters, medication) and outcome are systematically collected.

Our aim is to gain a better insight into the clinical profile and pathophysiology of TTC.

Detailed Summary:

Registry is an open-ended study and eligible individuals are assessed at index event and follow-up on their phenotypical characteristics. Furthermore, outcome data are collected (by clinical visits or telephone follow-up).

In addition, participants are given the option to consent to the donation of biosamples for the purposes to identify TTC specific biomarkers and mutations (sub-study on behalf of the registry).

Sponsor: University of Zurich

Current Primary Outcome: Natural history of TTC [ Time Frame: 10 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Cardiovascular complications, recurrence of TTC and all cause mortality [ Time Frame: at hospitalizsation, short term (1 year) and long term (10 years) ]

Original Secondary Outcome: Cardiovascular complications, recurrence of TTC and all cause mortality [ Time Frame: at hospitalizsation and long term (10 years) ]

Information By: University of Zurich

Dates:
Date Received: September 9, 2013
Date Started: January 2011
Date Completion: December 2020
Last Updated: May 20, 2014
Last Verified: May 2014